Zacks Small Cap Research on MSN4d
MTVA: Compelling Data for DA-1241 in Phase 2a MASH Trial…
MTVA READ THE FULL MTVA RESEARCH REPORT Business Update Compelling Results for DA-1241 in Phase 2a MASH Trial On December 18, 2024, MetaVia Inc. (NASDAQ:MTVA) announced positive topline results from ...
조선일보6d
Ildong Pharmaceutical reapplies for COVID-19 treatment approval with new data
Ildong Pharmaceutical stated on the 19th that it will supplement the clinical trial data for the oral antiviral drug ...